187
Participants
Start Date
May 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
October 31, 2008
eculizumab
St. James's Hospital, Cancer Clinical Trial Office, Dublin
Ucl St. Luc, Hematology Department, Brussels
Royal North Shore Hospital, Haematology Department, Saint Leonards
Royal Melbourne Hospital, Department of Clinical Haematology & Medical Oncology, Parkville
Princess Alexandra Hospital, Oncology Haematology Radiation Department, Woolloongabba
The Queen Elizabeth Hospital, Haematology/Oncology Department, Woodville South
The Royal Perth Hospital, Department of Haematology/Level 2, Perth
UMC St. Radboud, Department of Hematology, Nijmegen
NYU Clinical Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
Presbyterian Medical Center, PENN Comprehensive Hemophilia & Thombosis Program, Philadelphia
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda
Johns Hopkins University Medical Center, Baltimore
Duke University Medical Center, Division Cell Therapy, Heme Malignancies Program, Durham
Hospital De La Paz, Servicio de Hematologia, Madrid
Cleveland Clinic Florida, Department of Clinical Research, Weston
Cleveland Clinic Foundation, Cleveland
Indianapolis University Cancer Center, Indianapolis
Azienda Ospedaliera Universitaria Careggi, Dipartimento di area critica medico-chirurgica, Florence
Mayo Clinic, Divison of Hematology, Rochester
Washington University, Department of Internal Medicine/Division of Hematology, St Louis
Stanford University Medical Center, Division of Hematology, Stanford
Hartford Hospital, Cancer Clinical Research Office, Hartford
Massachusetts General Hospital, Boston
University of Alberta, Cross Cancer Institute, Edmonton
London Regional Cancer Centre, Clinical Research Unit Room C3080, London
Hopital Saint Louis, Centre d'investigation Clinique, Paris
Universitatsklinikum Essen, Zentrum fur Innere Medizin, Essen
Medizinische Hochschule Hannover, Abt. Hamatologie/Onkologie, Zentrum fur Innere Medizin, Hanover
Universitatskliniken des Saarlandes, Innere Medizin 1, Homburg/Saar
Institut fur Klinische Transfusionmedizin und Immunogenetik, Abtlg. Transfusionmedizin des Univ. Ulm, Ulm
Ospedale San Martino, Department of Hematology, Genova
Ospedale Maggiore di Milano, Divisione di Ematologia, Milan
Universita degli Studi di Napoli, Divisione di Ematologia, Azienda Universitar Policlinico, Napoli
Ospedale San Bortolo, Divisione di Ematologia, Vicenza
Hospital Clinic i Provincial, Servicio de Hematologia, Barcelona
Hospital Universitario Germans Trias I Pujol, Servicio de Hematologia, Barcelona
Stockholm South Hospital, Division of Hematology, Stockholm
Leeds General Infirmary, D Floor Brotherton Wing, Leeds
St. George's Hospital, Department of Haematology, London
Lead Sponsor
Alexion Pharmaceuticals, Inc.
INDUSTRY